Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
Tommaso Lorenzo Parigi, Ferdinando D’Amico, María T. Abreu, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 9, pp. 853-859
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease
Zhangpeng Shi, Xiaohong Li, Jufeng Chen, et al.
Bioactive Materials (2024) Vol. 35, pp. 167-180
Open Access | Times Cited: 18
Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China
Xin Jin, Kefang Sun, Liying Wang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access | Times Cited: 2
Efficacy and Safety of Upadacitinib in the Treatment of Chronic Pouchitis, Cuffitis, and Crohn's Disease of the Pouch
Nan Lan, Bo Shen
ACG Case Reports Journal (2024) Vol. 11, Iss. 1, pp. e01245-e01245
Open Access | Times Cited: 10
Biomarkers in inflammatory bowel disease: a practical guide
Jennifer Clough, Michael Colwill, Andrew Poullis, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 9
Challenges in IBD Research 2024: Precision Medicine
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 9
Pouchitis: pathophysiology and management
Bo Shen
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 7, pp. 463-476
Closed Access | Times Cited: 8
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
Marcello Imbrizi, Fernando Magro, Cláudio Saddy Rodrigues Coy
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1272-1272
Open Access | Times Cited: 18
Polymeric DNase-I nanozymes targeting neutrophil extracellular traps for the treatment of bowel inflammation
Chi‐Pin James Wang, Ga Ryang Ko, Yun Young Lee, et al.
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations
Di Liu, Meiling Cao, Haotian Wang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review
Javier Plaza Zamora, Alejandro Mínguez, Guillermo Bastida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 6
Difficult‐to‐treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment
Bénédicte Caron, Alexandre Habert, Olivier Bonsack, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 5, pp. 605-613
Open Access | Times Cited: 5
The concept of difficult-to-treat disease in rheumatology: where next?
György Nagy, Lilla Gunkl-Tóth, András M Dorgó, et al.
The Lancet Rheumatology (2025)
Closed Access
Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway
Ju Huang, Jing Li, Zhijun Geng, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Pouchitis unveiled: exploring clinical features, diagnosis, and cutting-edge treatments
Francesca Lusetti, Camilla de Almeida Martins, Munique Kurtz de Mello, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Dual Therapy in Inflammatory Bowel Disease
Gabriele Altieri, Alessandra Zilli, Tommaso Lorenzo Parigi, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 222-222
Open Access
Association of Poor Sleep Quality With Adverse Outcomes in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis
Tian Xu, Yue Zhang, S. Zhao
Journal of Digestive Diseases (2025)
Closed Access
The successful treatment of refractory Crohn's disease by high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation: a clinical case
Е. Г. Ганич, О. Б. Щукина, A. Yu. Polushin, et al.
Almanac of Clinical Medicine (2025)
Open Access
Efficacy of Dietary Supplementation in the Relief of Inflammatory Bowel Disease: A Systematic Review of Animal Studies
Natália Mulinari Turin de Oliveira, Carolina Silva Schiebel, Karien Sauruk da Silva, et al.
Nutrition Reviews (2025)
Closed Access
Advanced Combination Therapy with Biologics and Upadacitinib in Refractory Inflammatory Bowel Disease: A Retrospective Study from Taiwan
Ming-Jung Meng, Chia‐Jung Kuo, Ming-Wei Lai, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2733-2742
Open Access
Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn’s disease: a prospective trial
Biao Zou, Shengxuan Liu, Chen Dong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis
Nouran Alwisi, Rana Ismail, Hissa Al-Kuwari, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 702-702
Open Access
CO‐Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity
Hongyang Lu, Qiang Zhou, Jiayu Li, et al.
Advanced Science (2025)
Open Access
Comparative Efficacy of Subcutaneous Compared to Intravenous Biologics for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Nouran Alwisi, Rana Ismail, Hissa Al-Kuwari, et al.
Gastroenterology Insights (2025) Vol. 16, Iss. 2, pp. 12-12
Open Access
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study
Olga Maria Nardone, Giulio Calabrese, Alessia La Mantia, et al.
Crohn s & Colitis 360 (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Efficacy and safety of stem cell therapy for Crohn’s disease: a meta-analysis of randomized controlled trials
Yunfeng Qiu, Changfeng Li, Shihou Sheng
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top